Objective: Media coverage of psychotropic medications affects public views and patients’ and therapists’ compliance. This study is aimed to identify characteristics of and differences between medical and lay press presentations of psychotropic drugs. Methods: Two leading German medical and three lay press journals were analyzed in seven annual sets, ranging from 1963 to 1996. Results: There is a clear difference in the reporting on psychotropic drugs between the different types of journals. Lay press journals primarily focuss on minor tranquilizers and hypnotics which are indiscriminately presented as one group with other psychotropics, have a rather critical view on these drugs and underrepresent the needs for treatment of major mental illnesses. There were no marked trends over time in the attitude towards psychotropics. On comparing the publications before and after 1984, when benzodiazepines were put under schedule IV by WHO, differences in reports on dependency problems can only be found for the daily newspaper. Conclusion: It is the responsibility of psychiatrists to enter the public discussion on how psychiatric disorders should be treated and to run public ”awareness programmes”.
References
-
1
Angermeyer M C, Matschinger H.
Laientheorien über schizophrene Störungen und deren Behandlung.
Fortschr Neurol Psychiatr.
1992;
60 (Sonderheft 2)
105-106
-
2
Angermeyer M C, Däumer R, Matschinger H.
Benefits and risks of psychotropic medications in the eyes of the general public: results of a survey in the Federal Republic of Germany.
Pharmacopsychiatry.
1993;
26
114-120
-
3
Angermeyer M C, Matschinger H.
Public attitude towards psychiatric treatment.
Acta Psychiatr Scand.
1996;
94
326-336
-
4
Angermeyer M C, Matschinger H.
Public attitudes towards psychotropic drugs: Have there been any changes in recent years?.
Pharmacopsychiatry.
2004;
37
152-156
-
5
Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig S C, Weissbecker H, Kepplinger H M, Sobota K.
Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.
J Nerv Ment Dis.
1997;
185
151-158
-
6 Benkert O, Kepplinger H M, Sobota K. Psychopharmaka im Widerstreit: Eine Studie zur Akzeptanz von Psychopharmaka - Bevölkerungsumfrage und Medienanalyse. Berlin; Springer-Verlag 1995
-
7
Brown S D, Landry F J.
Recognizing, reporting, and reducing adverse drug reactions.
South Med J.
2001;
94
370-373
-
8 Bury M, Gabe J. Hooked? Media responses to tranquillizer dependence. In: Abbot P, Payne G, editors New Directions in the Sociology of Health London. Palmer Press 1990a
-
9 Bury M, Gabe J. A sociological view of tranquillizer dependence: challenges and responses. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, editors Benzodiazepines: Current Concepts (Biological, Clinical and Social Perspectives). New York; John Wiley and Sons 1990b
-
10
Cassels A, Hughes M A, Cole C, Mintzes B, Lexchin J, McCormack J P.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ.
2003;
168
1133-1137
-
11
Cohen L, Morgan P P.
Medical dramas and the press: who benefits from coverage?.
CMAJ.
1988;
139
657-661
-
12
Cooperstock R, Lennard H L.
Some social meanings of tranquillizer use.
Sociology of Health and Illness.
1979;
1
331-347
-
13
Dewan M J, Levy B F, Donnelly M P.
A positive view of psychiatrists and psychiatry.
Compr Psychiatry.
1988;
29
523-531
-
14
Franz M, Dilo K.
Schepank H. Warum „nein“ zur Psychotherapie? Kognitive Stereotypen psychogen erkrankter Patienten aus einer Bevölkerungsstichprobe im Zusammenhang mit der Ablehnung eines Psychotherapieangebotes.
Psychother Psychosom Med Psychol.
1993;
43
278-285
-
15
Gabe J, Bury M.
Tranquillisers as a social problem.
Sociol Rev.
1988;
36
320-352
-
16
Gabe J, Gustafsson U, Bury M.
Mediating illness: newspaper coverage of tranquilliser dependence.
Sociol Health Illness.
1991;
13
332-353
-
17
Gaebel W.
Qualitätssicherung in der Psychiatrie.
Nervenarzt.
1995;
66
481-493
-
18
Gaebel W.
Psychiatrie und Öffentlichkeit.
Nervenarzt.
1996;
67
336-337
-
19 Gaedt F, Gaedt C, Reuband K H. Zur Rauschmittelberichterstattung der Tageszeitungen in der Bundesrepublik Deutschland und West-Berlin. Ergebnisse einer Inhaltsanalyse. In: Reuband KH, editor Rauschmittelkonsum: soziale Abweichung und institutionelle Reaktion. Wiesbaden; Akademische Verlagsgesellschaft 1976: pp. 77-107
-
20 Gerbner G. Toward cultural indicators: The analysis of mass mediated public message systems. In: Gerbner G, Holst OR, Krippendorf K, Paisley WJ, Stone PJ, editors The analysis of communication content. New York; John Wiley and Sons 1969: p. 126
-
21 Helman C G. ‘Tonic’, ‘fuel’, and ‘food’: social and symbolic aspects of the long-term use of psychotropic drugs. In: Gabe J, Williams P, editors Tranquillisers: Social, Psychological and Clinical Perspectives. London; Travistock Publications 1986: pp. 199-225
-
22
Hillert A, Sandmann J, Benkert O.
Is there a general rejection of psychotropic drugs? Knowledge and attitudes of the lay public.
Pharmacopsychiatry.
1993;
26
162
-
23
Hillert A, Sandmann J, Ehmig S C, Sobota K, Weisbecker W, Kepplinger H M, Benkert O.
Psychopharmacological drugs as represented in the press: results of systematic analysis of newspapers and popular magazines.
Pharmacopsychiatry.
1996;
29
67-71
-
24
Hoffmann-Richter U, Forrer F, Finzen A.
Die Schizophrenie in der Frankfurter Allgemeinen Zeitung - ein Lehrstück.
Psychiatr Prax.
2003;
30
4-7
-
25
Hornung W P.
Kooperative Pharmakotherapie.
Dt Ärztebl.
1996;
93
A-1465 - 1468
-
26
Ioannou C.
Media coverage versus Fluoxetine as the the cause of suicidal ideation.
Am J Psychiatry.
1992;
149
572
-
27
Katschnig H, Etzersdorfer M M.
Vorstellungen in der österreichischen Bevölkerung über Natur, Verlauf und Behandelbarkeit psychischer Erkrankungen.
Fortschr Neurol Psychiatr.
1992;
60 (Sonderheft 2)
168
-
28
Kok G, van den Borne B, Mullen P D.
Effectiveness of health education and health promotion: meta analyses of effect studies and determinants of effectiveness.
Patient Educat Counsel.
1997;
30
19-27
-
29
Kroll A, Dietrich S, Angermeyer C.
Die Darstellung der Depression in deutschen Tageszeitungen. Eine Trendanalyse.
Psychiatr Prax.
2003;
30
367-371
-
30
Lamontagne Y, Elie R, Gaydos S, Garceau-Durand Y.
Information on mental illness. The use of newspapers, leaflets or both: a comparative study.
Can J Pub Health.
1986;
27
56-57
-
31
Lamontagne Y.
The public image of psychiatrists.
Can J Psychiatry.
1990;
35
693-695
-
32
Leimkühler A M, Müller U.
Patientenzufriedenheit - Artefakt oder soziale Tatsache?.
Nervenarzt.
1996;
67
765-773
-
33 Linden M. Report on the study on the impact of scheduling benzodiazepines in the Federal Republic of Germany. Report for the World Health Organization. Geneva 1990
-
34
Linden M, Kiermeir J.
Medizinische Diagnostik und Therapie als kooperativer Problemlöseprozess von Arzt und Patient. Von der „evidenzbasierten“ zur „rationalen evidenzbasierten“ Medizin.
Die Psychiatrie.
2004;
1
42-49
-
35
Manheimer D I, Davidson S T, Balter M B, Mellinger G D, Cisin I H, Parry H J.
Popular attitudes and beliefs about tranquillizers.
Am J Psychiatry.
1973;
130
1246-1253
-
36
Morgan J P.
Cultural and medical attitudes toward benzodiazepines: conflicting metaphors.
J Psychoactive Drugs.
1983;
15
115-120
-
37 Scheibler F, Pfaff H. Shared decision making. Der Patient als Partner im medizinischen Entscheidungsprozess. Weinheim; Juventa 2003
-
38
Shader R I, Greenblatt D J, Balter M B.
Appropriate use and regulatory control of benzodiazepines.
J Clin Pharmacol.
1991;
3
781-784
-
39
Thompson J B.
Mass communication and modern culture: contribution to a critical theory of ideology.
Sociology.
1988;
22
359-383
-
40
Toutoungi N.
Impact of media on drug consumption.
Agressologie.
1989;
30
545-546
-
41
Tyrer P.
Medicine and the media.
BMJ.
1984;
288
1531
-
42 Vartanian M E, Morozov P V, Khan I. Conclusions and recommendations. In: Vartanian ME, Morozov PV, Khan I, editors Rational Use of Psychotropic Drugs with Special Emphasis on Non-Psychiatric Settings. Amsterdam; Exerpta Medica 1987: p. vii
-
43
Waldron I.
Increased prescribing of Valium, Librium and other drugs - an example of the influence of economic and social factors on the practice of medicine.
Int J Health Serv.
1977;
7
37-62
-
44 Winckelmann H J. Selbstmedikation und der therapiebestimmende Patient. In: Heinrich K, Linden M, Müller-Oerlinghausen B, editors Werden zu viele Psychopharmaka verbraucht?. Stuttgart; Georg Thieme Verlag 1989: pp. 141-152
-
45 Winick C. Reporting drug truth in the media. In: Morgan JP, Kagan DV, editors Society and Medication: Conflicting Signals for Prescribers and Patients Lexington. Massachusetts; Lexington Books 1983
-
46
Woods J H.
Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.
Drug Alcohol Depend.
1990;
25
229-233
Prof. Dr. Michael Linden
Research Group Psychosomatic Rehabilitation Charité
University Hospital Benjamin Franklin
Hs IV, Rm. 524
Hindenburgdamm 30
12209 Berlin
Germany
Phone: +49 30 8445 4778, +49 3328 345678
Fax: +49 30 8445 4778, +49 3328 345555
Email: linden@zedat.fu-berlin.de
